Royalty Pharma plc Share Price Today: Live Updates & Key Insights

Royalty Pharma plc share price today is $44.47, up -0.37%. The stock opened at $45.59 against the previous close of $45.53, with an intraday high of $45.6 and low of $44.74.

Royalty Pharma plc Share Price Chart

Royalty Pharma plc

us-stock
To Invest in {{usstockname}}
us-stock

Royalty Pharma plc Share Price Performance

$44.47 -0.0037(-0.37%) RPRX at 23 Mar 2026 03:04 PM Biotechnology
Lowest Today 44.74
Highest Today 45.6
Today’s Open 45.59
Prev. Close 45.53
52 Week High 47.86
52 Week Low 28.97
Day’s Range: Low 44.74 High 45.6
52-Week Range: Low 28.97 High 47.86
1 day return -
1 Week return -1.54
1 month return -0.17
3 month return +16.81
6 month return +26.61
1 year return +34.6
3 year return -
5 year return -
10 year return -

Royalty Pharma plc Institutional Holdings

Morgan Stanley - Brokerage Accounts 10.31

Capital Research & Mgmt Co - Division 3 7.26

FMR Inc 6.13

BlackRock Inc 6.12

Baillie Gifford & Co Limited. 3.97

Swedbank AB 2.79

Adage Capital Partners Gp LLC 2.74

State Street Corp 2.40

American Funds New Perspective A 2.36

Capital Group New Perspective Comp 2.36

Vanguard Group Inc 2.32

American Funds American Balanced A 1.87

Geode Capital Management, LLC 1.80

Caledonia (Private) Investments Pty Ltd 1.72

MS INVF US Advantage I 1.33

Morgan Stanley Growth 1.28

Morgan Stanley Growth SMA 1.28

Morgan Stanley Inst Growth I 1.28

Citadel Advisors Llc 1.23

Victory Capital Management Inc. 1.19

Jane Street Group LLC 1.15

American Funds Growth Fund of Amer A 1.02

Capital Group Growth Fnd of Amer Comp 1.02

VictoryShares Free Cash Flow ETF 0.99

Northern Trust Corp 0.95

Vanguard Institutional Extnd Mkt Idx Tr 0.95

Swedbank Robur Transfer 70 0.86

Swedbank Robur Aktiefond Pension 0.86

MS INVF US Growth I 0.83

JPMorgan Chase & Co 0.82

NORGES BANK 0.80

Patients Capital Management LLC 0.78

Arrowstreet Capital Limited Partnership 0.77

UBS Asset Mgmt Americas Inc 0.73

Strategic Advisers Fidelity US TtlStk 0.73

Fidelity Dividend Growth 0.66

Patient Opportunity C 0.58

State St Russell Sm/Mid Cp® Indx SL Cl I 0.53

Transamerica Capital Growth A 0.51

Fidelity Extended Market Index 0.46

Royalty Pharma plc Market Status

Strong Buy: 4

Buy: 2

Hold: 2

Sell: 0

Strong Sell: 0

Royalty Pharma plc Fundamentals

Market Cap 26236.64 M

PB Ratio 3.0116

PE Ratio 25.4831

Enterprise Value 26964.93 M

Total Assets 19620.78 M

Volume 8391483

Royalty Pharma plc Company Financials

Annual Revenue FY25:2378193000 2378.2M, FY24:2264000000 2264.0M, FY23:2324234000 2324.2M, FY22:2237215000 2237.2M, FY21:2289463000 2289.5M

Annual Profit FY25:2378193000 2378.2M, FY24:2264000000 2264.0M, FY23:null 0.0M, FY22:2231545000 2231.5M, FY21:2266467000 2266.5M

Annual Net worth FY25:770947000 770.9M, FY24:859000000 859.0M, FY23:184410000 184.4M, FY22:42832000 42.8M, FY21:478754000 478.8M

Quarterly Revenue Q4/2025:621990000 622.0M, Q3/2025:609291000 609.3M, Q2/2025:578665000 578.7M, Q1/2025:568247000 568.2M, Q4/2024:594000000 594.0M

Quarterly Profit Q4/2025:621990000 622.0M, Q3/2025:609291000 609.3M, Q2/2025:578665000 578.7M, Q1/2025:568247000 568.2M, Q4/2024:594000000 594.0M

Quarterly Net worth Q4/2025:214205000 214.2M, Q3/2025:288217000 288.2M, Q2/2025:30176000 30.2M, Q1/2025:238349000 238.3M, Q4/2024:208000000 208.0M

About Royalty Pharma plc & investment objective

Company Information Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

Organisation Biotechnology

Employees 100

Industry Biotechnology

CEO Mr. Pablo Legorreta

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Royalty Pharma plc FAQs

What is the share price of Royalty Pharma plc today?

The current share price of Royalty Pharma plc is $44.47.

Can I buy Royalty Pharma plc shares in India?

Yes, Indian investors can buy Royalty Pharma plc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Royalty Pharma plc shares in India?

You can easily invest in Royalty Pharma plc shares from India by:

Can I buy fractional shares of Royalty Pharma plc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Royalty Pharma plc?

Royalty Pharma plc has a market cap of $26236.64 M.

In which sector does Royalty Pharma plc belong?

Royalty Pharma plc operates in the Biotechnology sector.

What documents are required to invest in Royalty Pharma plc stocks?

To invest, you typically need:

What is the PE and PB ratio of Royalty Pharma plc?

The PE ratio of Royalty Pharma plc is 25.48 and the PB ratio is 3.01.